1
|
Friedlander Y, Munidasa S, Thakar A, Ragunayakam N, Venegas C, Kjarsgaard M, Zanette B, Capaldi DPI, Santyr G, Nair P, Svenningsen S. Phase-Resolved Functional Lung (PREFUL) MRI to Quantify Ventilation: Feasibility and Physiological Relevance in Severe Asthma. Acad Radiol 2024; 31:3416-3426. [PMID: 38378325 DOI: 10.1016/j.acra.2024.01.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2023] [Revised: 01/28/2024] [Accepted: 01/28/2024] [Indexed: 02/22/2024]
Abstract
RATIONALE AND OBJECTIVES Emergent evidence in several respiratory diseases supports translational potential for Phase-Resolved Functional Lung (PREFUL) MRI to spatially quantify ventilation but its feasibility and physiological relevance have not been demonstrated in patients with asthma. This study compares PREFUL-derived ventilation defect percent (VDP) in severe asthma patients to healthy controls and measures its responsiveness to bronchodilator therapy and relation to established measures of airways disease. MATERIALS AND METHODS Forty-one adults with severe asthma and seven healthy controls performed same-day free-breathing 1H MRI, 129Xe MRI, spirometry, and oscillometry. A subset of participants (n = 23) performed chest CT and another subset of participants with asthma (n = 19) repeated 1H MRI following the administration of a bronchodilator. VDP was calculated for both PREFUL and 129Xe MRI. Additionally, the percent of functional small airways disease was determined from CT parametric response maps (PRMfSAD). RESULTS PREFUL VDP measured pre-bronchodilator (19.1% [7.4-43.3], p = 0.0002) and post-bronchodilator (16.9% [6.1-38.4], p = 0.0007) were significantly greater than that of healthy controls (7.5% [3.7-15.5]) and was significantly decreased post-bronchodilator (from 21.9% [10.1-36.9] to 16.9% [6.1-38.4], p = 0.0053). PREFUL VDP was correlated with spirometry (FEV1%pred: r = -0.46, p = 0.0023; FVC%pred: r = -0.35, p = 0.024, FEV1/FVC: r = -0.46, p = 0.0028), 129Xe MRI VDP (r = 0.39, p = 0.013), and metrics of small airway disease (CT PRMfSAD: r = 0.55, p = 0.021; Xrs5 Hz: r = -0.44, p = 0.0046, and AX: r = 0.32, p = 0.044). CONCLUSION PREFUL-derived VDP is responsive to bronchodilator therapy in asthma and is associated with measures of airflow obstruction and small airway dysfunction. These findings validate PREFUL VDP as a physiologically relevant and accessible ventilation imaging outcome measure in asthma.
Collapse
Affiliation(s)
- Yonni Friedlander
- Firestone Institute for Respiratory Health, St. Joseph's Healthcare Hamilton, Hamilton, Canada
| | - Samal Munidasa
- Translational Medicine Program, The Hospital for Sick Children, Toronto, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada
| | - Ashutosh Thakar
- Department of Medicine, McMaster University, Hamilton, Canada
| | | | - Carmen Venegas
- Firestone Institute for Respiratory Health, St. Joseph's Healthcare Hamilton, Hamilton, Canada; Department of Medicine, McMaster University, Hamilton, Canada
| | - Melanie Kjarsgaard
- Firestone Institute for Respiratory Health, St. Joseph's Healthcare Hamilton, Hamilton, Canada; Department of Medicine, McMaster University, Hamilton, Canada
| | - Brandon Zanette
- Translational Medicine Program, The Hospital for Sick Children, Toronto, Canada
| | - Dante P I Capaldi
- Department of Radiation Oncology, Division of Physics, University of California, San Francisco, CA
| | - Giles Santyr
- Translational Medicine Program, The Hospital for Sick Children, Toronto, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada
| | - Parameswaran Nair
- Firestone Institute for Respiratory Health, St. Joseph's Healthcare Hamilton, Hamilton, Canada; Department of Medicine, McMaster University, Hamilton, Canada
| | - Sarah Svenningsen
- Firestone Institute for Respiratory Health, St. Joseph's Healthcare Hamilton, Hamilton, Canada; Department of Medicine, McMaster University, Hamilton, Canada.
| |
Collapse
|
2
|
Moore WH, Chandarana H. The Role of Proton MRI to Evaluate Patient Pathophysiology in Severe Asthma. Radiol Cardiothorac Imaging 2023; 5:e230372. [PMID: 38166342 PMCID: PMC11163240 DOI: 10.1148/ryct.230372] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2023] [Revised: 11/20/2023] [Accepted: 11/20/2023] [Indexed: 01/04/2024]
Affiliation(s)
- William H. Moore
- From the Department of Radiology, New York University, 660 1st
Ave, New York, NY 10016 (W.H.M.); Department of Radiology, Center for Advanced
Imaging Innovation and Research, New York, NY (H.C.); and Department of
Radiology and Biomedical Imaging, NYU Grossman School of Medicine, New York, NY
(H.C.)
| | - Hersh Chandarana
- From the Department of Radiology, New York University, 660 1st
Ave, New York, NY 10016 (W.H.M.); Department of Radiology, Center for Advanced
Imaging Innovation and Research, New York, NY (H.C.); and Department of
Radiology and Biomedical Imaging, NYU Grossman School of Medicine, New York, NY
(H.C.)
| |
Collapse
|